Medifast (MED) Tops Q4 EPS by 148c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $9.68 +2.43%
EPS Growth %: -295.5%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
ORPB, ONEG, NDLS, More
EPS Growth %: -295.5%
Financial Fact:
Revenue: 68.58M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $3.70, $1.48 better than the analyst estimate of $2.22. Revenue for the quarter came in at $337.2 million versus the consensus estimate of $330.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
- TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
